BACKGROUND: Nanophthalmos is a genetic disorder characterized by very small, hyperopic eyes that are without gross structural defects. Recessive nanophthalmos is caused by severe mutations in the MFRP gene, which encodes a Frizzled-related transmembrane protein that is selectively expressed in the retinal pigment epithelium (RPE) and ciliary body. RESULTS: For two MFRP -/- adults, we have obtained records of refraction that begin in early childhood. At the age of 6 months, one patient's eyes already had a refractive error of +12.25 D, and over the next 20 years this slowly increased to +17.50 D. Adults homozygous for null mutations in MFRP have eyes with axial lengths shorter than those of normal newborns. Furthermore, the unusually high curvature of their corneas is consistent with eyes that had been smaller than normal during late fetal development. MFRP protein was first detected at 14 weeks of gestation, when it was restricted to the posterior pole RPE. By 20 weeks gestation, MFRP expression had spread laterally, and was found throughout the RPE. MFRP protein was detected in both posterior and lateral RPE of the adult eye. CONCLUSIONS: Embryonic function of the MFRP gene appears necessary for the eye to reach its full size at birth. Its onset of expression in the RPE during mid-gestation suggests that MFRP does not participate in early formation of the optic cup, and is consistent with a role in later growth and development of the eye. Patients without MFRP gene function exhibit no correction of refractive error during childhood, which suggests that this gene is essential for emmetropization, a complex process by which vision regulates axial growth of the eye.
BACKGROUND: Nanophthalmos is a genetic disorder characterized by very small, hyperopic eyes that are without gross structural defects. Recessive nanophthalmos is caused by severe mutations in the MFRP gene, which encodes a Frizzled-related transmembrane protein that is selectively expressed in the retinal pigment epithelium (RPE) and ciliary body. RESULTS: For two MFRP -/- adults, we have obtained records of refraction that begin in early childhood. At the age of 6 months, one patient's eyes already had a refractive error of +12.25 D, and over the next 20 years this slowly increased to +17.50 D. Adults homozygous for null mutations in MFRP have eyes with axial lengths shorter than those of normal newborns. Furthermore, the unusually high curvature of their corneas is consistent with eyes that had been smaller than normal during late fetal development. MFRP protein was first detected at 14 weeks of gestation, when it was restricted to the posterior pole RPE. By 20 weeks gestation, MFRP expression had spread laterally, and was found throughout the RPE. MFRP protein was detected in both posterior and lateral RPE of the adult eye. CONCLUSIONS: Embryonic function of the MFRP gene appears necessary for the eye to reach its full size at birth. Its onset of expression in the RPE during mid-gestation suggests that MFRP does not participate in early formation of the optic cup, and is consistent with a role in later growth and development of the eye. Patients without MFRP gene function exhibit no correction of refractive error during childhood, which suggests that this gene is essential for emmetropization, a complex process by which vision regulates axial growth of the eye.
Authors: M I Othman; S A Sullivan; G L Skuta; D A Cockrell; H M Stringham; C A Downs; A Fornés; A Mick; M Boehnke; D Vollrath; J E Richards Journal: Am J Hum Genet Date: 1998-11 Impact factor: 11.025
Authors: N L Hawes; B Chang; G S Hageman; S Nusinowitz; P M Nishina; B S Schneider; R S Smith; T H Roderick; M T Davisson; J R Heckenlively Journal: Invest Ophthalmol Vis Sci Date: 2000-09 Impact factor: 4.799
Authors: Imran A Bhutto; Sahng Y Kim; D Scott McLeod; Carol Merges; Naomi Fukai; Bjorn R Olsen; Gerard A Lutty Journal: Invest Ophthalmol Vis Sci Date: 2004-05 Impact factor: 4.799
Authors: Astra Dinculescu; Jackie Estreicher; Juan C Zenteno; Tomas S Aleman; Sharon B Schwartz; Wei Chieh Huang; Alejandro J Roman; Alexander Sumaroka; Qiuhong Li; Wen-Tao Deng; Seok-Hong Min; Vince A Chiodo; Andy Neeley; Xuan Liu; Xinhua Shu; Margarita Matias-Florentino; Beatriz Buentello-Volante; Sanford L Boye; Artur V Cideciyan; William W Hauswirth; Samuel G Jacobson Journal: Hum Gene Ther Date: 2012-01-26 Impact factor: 5.695
Authors: Jungyeon Won; Jeremy R Charette; Vivek M Philip; Timothy M Stearns; Weidong Zhang; Jürgen K Naggert; Mark P Krebs; Patsy M Nishina Journal: Exp Eye Res Date: 2013-11-04 Impact factor: 3.467
Authors: Rosemarie A Wasmann; Jolien S Klein Wassink-Ruiter; Olof H Sundin; Elisa Morales; Joke B G M Verheij; Jan Willem R Pott Journal: Acta Ophthalmol Date: 2013-06-07 Impact factor: 3.761
Authors: Rajarshi Mukhopadhyay; Panagiotis I Sergouniotis; Donna S Mackay; Alexander C Day; Genevieve Wright; Sophie Devery; Bart P Leroy; Anthony G Robson; Graham E Holder; Zheng Li; Andrew R Webster Journal: Mol Vis Date: 2010-03-26 Impact factor: 2.367
Authors: Yao Li; Wen-Hsuan Wu; Chun-Wei Hsu; Huy V Nguyen; Yi-Ting Tsai; Lawrence Chan; Takayuki Nagasaki; Irene H Maumenee; Lawrence A Yannuzzi; Quan V Hoang; Haiqing Hua; Dieter Egli; Stephen H Tsang Journal: Mol Ther Date: 2014-06-04 Impact factor: 11.454